Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
159
-
Total shares
-
48.4M
-
Shares change
-
+1.08M
-
Total reported value, excl. options
-
$1.43B
-
Value change
-
-$10.5M
-
Put/Call ratio
-
0.56
-
Number of buys
-
104
-
Number of sells
-
-67
-
Price
-
$29.55
Significant Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q2 2019
173 filings reported holding AERI - AERIE PHARMACEUTICALS INC - COM as of Q2 2019.
AERIE PHARMACEUTICALS INC - COM (AERI) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.4M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.36M shares), VANGUARD GROUP INC (4.19M shares), BlackRock Inc. (3.36M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.03M shares), Foresite Capital Management III, LLC (1.95M shares), WADDELL & REED FINANCIAL INC (1.74M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.7M shares), Foresite Capital Management II, LLC (1.67M shares), Bank of New York Mellon Corp (1.56M shares), and Consonance Capital Management LP (1.51M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.